Published: 2022-09-28

Associated factors and virologic outcomes of cisgender groups among people living with HIV/AIDS attending a tertiary health facility in Rivers State, Nigeria

Anwuri Luke, Golden Owhonda, Bright O. Ogbondah, Charles I. Tobin-West


Virologic outcome is the assessment of an human immuno-deficiency virus (HIV)-positive patient response antiretroviral therapy adherence using real-time polymerase chain reaction assays after two consecutive viral load measurements ≥3 months apart. This study aimed to assess the associated factors of virologic outcomes among cisgender groups of people living with HIV/AIDS attending a tertiary health facility in Rivers State, Nigeria. This comparative cross-sectional study was conducted at the antiretroviral therapy clinic of the University of Port Harcourt Teaching Hospital from September 2020 to November 2020. The systematic sampling technique was employed to select 1600 participants; females (800), and males (800). Data was collected using a 3-item structured interviewer-administered questionnaire. Statistical package for social science (SPSS) version-25 was used to analyze data. Test of association was done using Chi-square, Fisher’s exact and spearman rho test and set at a significance level of p<0.05 and 95% CI. Confounding variables were controlled using multiple logistic regression analysis. A total of 1600 participants; males (800), and females (800) were recruited. The study reported a mean age and standard deviation: male (44.53±10.50), female (40.58±9.34); virologic suppression levels; male (89.5%), female (89.6%). Having a treatment supporter (aOR=0.382; 95% CI=0.206-0.707; p=0.002) among the female gender was influenced by virologic outcome. The cisgender female group had slightly better virologic outcomes as opposed to the cisgender male group and this was significantly influenced by having a treatment supporter. Therefore, PLWHA should make personal efforts to participate in adherence counselling sessions and other HIV/AIDS support services offered at the ARV therapy clinics.


Associated factors, Virologic outcomes, Cisgender groups, People living with HIV/AIDS

Full Text:



Kharsany ABM, Karim QA. HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J. 2016;10(1):34-48.

Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV Statistics: Ending the AIDS Epidemic. Geneva, Switzerland. 2020;6. Available at: Accessed on 27 December 2020.

Becker N. Multi-Level Barriers to ART Adherence among HIV-Infected Women in Rural Eswatini: A Mixed Methods Approach [Doctor of Philosophy in Public Health]. The University of Massachusetts Amherst, United States of America. 2019;185. Available at: tations_2/1691/. Accessed 03 January 2021.

Opio D, Semitala FC, Kakeeto A, Sendaula E, Okimat P, Nakafeero B, et al. Loss to Follow-Up and Associated Factors among Adult People Living with HIV at Public Health Facilities in Wakiso District, Uganda: A Retrospective Cohort Study. BMC Health Serv Res. 2019;19(628):10.

Ojukwu CL. Effects of Nonadherence to HIV/AIDS Drugs on HIV-Related Comorbidities in Eastern Nigeria [Doctor of Philosophy in Public Health]. Walden University Minneapolis, United States of America; 2019;166. Available at: https://scholar Accessed 28 December 2020.

Nomoto R. Gender Equality: Glossary of Terms and Concepts. United Nations Children's Fund (UNICEF) Regional Office for South Asia Nepal, India. 2017;17. Available at: gender/training/content/resources/Glossary.pdf. Accessed on 25 December 2020.

Klaas NE, Thupayagale-Tshweneagae G, Makua TP. The Role of Gender in the Spread of HIV and AIDS among Farmworkers in South Africa. Afr J Prim Health Care Fam Med. 2018;10(1):8.

Girum T, Wasie A, Lentiro K, Muktar E, Shumbej T, Difer M, et al. Gender Disparity in Epidemiological Trend of HIV/AIDS Infection and Treatment in Ethiopia. Arch Public Health. 2018;76(51):10.

Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2020. Geneva, Switzerland: United Nations. 2020;436. Available at:

Federal Ministry of Health (FMOH). Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) 2018 Technical Report. Abuja, Nigeria; 2018:297. Available at: › Microsites › CIHEB › documentsPDF. Accessed on 08 April 2022.

Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2021. Geneva, Switzerland; 2021;468. Available at: https://www. Accessed on 23 April 2022.

Mukumbang FC, Mwale JC, van Wyk B. Conceptualizing the Factors Affecting Retention in Care of Patients on Antiretroviral Treatment in Kabwe District, Zambia, Using the Ecological Framework. AIDS Res Treat. 2017;7356362:11.

McMahon JM, Braksmajer A, Zhang C, Leblanc N, Chen M, Aidala A, et al. Syndemic Factors Associated with Adherence to Antiretroviral Therapy among HIV-Positive Adult Heterosexual Men. AIDS Res Ther. 2019;16(1):32.

Selamu LG, Singhe MS, Assefa E. The Psychosocial Factors that Influencing Antiretroviral Treatment Adherence. J Clin Res HIV AIDS Prev. 2017;3(1):31-9.

Chirambo L, Valeta M, Banda Kamanga TM, Nyondo-Mipando AL. Factors Influencing Adherence to Antiretroviral Treatment among Adults Accessing Care from Private Health Facilities in Malawi. BMC Public Health. 2019;19(1382):11.

Campbell L, Masquillier C, Thunnissen E, Ariyo E, Tabana H, Sematlane N, et al. Social and Structural Determinants of Household Support for ART Adherence in Low and Middle-Income Countries: A Systematic Review. Int J Environ Res Public Health. 2020;17(3808):28.

Avong YK, Aliyu GG, Jatau B, Gurumnaan R, Danat N, Kayode GA, et al. Integrating Community Pharmacy into Community Based Anti-Retroviral Therapy Program: A Pilot Implementation in Abuja, Nigeria. Plos One. 2018;13(1):10.

Adeniyi OV, Ajayi AI, Ter Goon D, Owolabi EO, Eboh A, Lambert J. Factors Affecting Adherence to Antiretroviral Therapy among Pregnant Women in the Eastern Cape, South Africa. BMC Infect Dis. 2018;18(175):11.

Joint United Nations Programme on HIV/AIDS (UNAIDS). HIV Care and Support Taking into Account: The 2016 WHO Consolidated Guidelines. Geneva, Switzerland. 2016;48. Available at: Accessed on 22 May 2022.

National AIDS and STIs Control Programme (NASCP). National Guidelines for HIV Prevention Treatment and Care (2016). Abuja, Nigeria. 2016;250. Available at: https://www.prepwatch. org/wp-content/uploads/2017/08/nigeria_national_ guidelines_2016.pdf. Accessed on 22 May 2022.

Bvochora T, Satyanarayana S, Takarinda KC, Bara H, Chonzi P, Komtenza B, et al. Enhanced Adherence Counselling and Viral Load Suppression in HIV Seropositive Patients with an Initial High Viral Load in Harare, Zimbabwe: Operational issues. PLoS One. 2019;14(2):13.

World Health Organization. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva, Switzerland. 2015;78. Available at: NBK327115/. Accessed on 22 May 2022.

Joint United Nations Programme on HIV/AIDS (UNAIDS). Global AIDS Monitoring 2021: Indicators for Monitoring the 2016 Political Declaration on Ending AIDS. Geneva, Switzerland. 2020;208. Available at: resources/documents/2020/global-aids-monitoring-guidelines. Accessed on 22 May 2022.

Ellman TM, Alemayehu B, Abrams EJ, Arpadi S, Howard AA, El‐Sadr WM. Selecting a Viral Load Threshold for Routine Monitoring in Resource‐Limited Settings: Optimizing Individual Health and Population Impact. J Int AIDS Soc. 2017;20(7):3.

Taieb F, Tram TH, Ho HT, Pham VA, Nguyen L, Pham BH, et al. Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338). Open Forum Infect Dis. 2016;3(3):7.

Ayele G, Tessema B, Amsalu A, Ferede G, Yismaw G. Prevalence and Associated Factors of Treatment Failure among HIV/AIDS Patients on HAART Attending University of Gondar Referral Hospital Northwest Ethiopia. BMC Immunol. 2018;19(37):13.

World Health Organization (WHO). Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach. Geneva, Switzerland; 2021;592. Available at: publications-detail-redirect/978924003159330. Accessed on 22 May 2022.

Diress G, Dagne S, Alemnew B, Adane S, Addisu A. Viral Load Suppression after Enhanced Adherence Counseling and Its Predictors among High Viral Load HIV Seropositive People in North Wollo Zone Public Hospitals, Northeast Ethiopia: Retrospective Cohort Study. AIDS Res Treat. 2020;8909232:9.

Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. United States of America. 2021;463. Available at: https://clinicalinfo. Accessed on 22 May 2022.

Henegar CE, Westreich DJ, Maskew M, Brookhart MA, Miller WC, Majuba P, et al. Comparison of Pharmacy-Based Measures of Adherence to Antiretroviral Therapy as Predictors of Virologic Failure. AIDS Behav. 2015;19(4):612-8.

Iacob SA, Iacob DG, Jugulete G. Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment: Clinical Points of View and Practical Considerations. Front Pharmacol. 2017;8(831):12.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375(9):830-9.

Marsh K, Eaton JW, Mahy M, Sabin K, Autenrieth CS, Wanyeki I, et al. Global, Regional and Country-Level 90-90-90 Estimates for 2018: Assessing Progress towards the 2020 Target. AIDS. 2019;33(3):213-26.

Morgan M, Dragon C, Daus G, Holzberg J, Kaplan R, Menne H, et al. Updates on Terminology of Sexual Orientation and Gender Identity Survey Measures. Federal Committee on Statistical Methodology, United States of America. 2020;32. Available at: Accessed on 22 May 2022.

United States President's Emergency Plan for AIDS Relief (PEPFAR). Nigeria Country Operational Plan (COP) 2020 Strategic Direction Summary. United States of America. 2020;71. Available at: › uploads › 2020/07 › COP. Accessed on 22 May 2022.

Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: A Tool for Screening Patient Adherence and Barriers to Adherence. Patient Educ Couns. 1999;37(2):113-24.

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis. Medicine (Baltimore). 2016;95(15):9.

Conan N, Simons E, Chihana ML, Ohler L, FordKamara E, Mbatha M, et al. Increase in HIV Viral Suppression in KwaZulu-Natal, South Africa: Community-Based Cross-Sectional Surveys 2018 and 2013. What Remains to be Done? Plos One. 2022;17(3):12.

Louis FJ, Buteau J, François K, Hulland E, Domerçant JW, Yang C, et al. Virologic Outcome among Patients Receiving Antiretroviral Therapy at Five Hospitals in Haiti. Plos One. 2018;13(1):12.

Andronescu L, Zulu PM, Jackson SS, Hachaambwa L, Claassen CW, Stafford KA. The Association between Gender and HIV Viral Suppression on Third-Line Therapy in Zambia: A Retrospective Cohort Study. Int J STD AIDS. 2019;30(5):453-9.

Ojha CR, Shakya G, Dumre SP. Virologic and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal. BioMed Res Int. 2016;681732:7.

Beer L, Mattson CL, Bradley H, Skarbinski J. Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression among HIV Patients in the United States. Medicine (Baltimore). 2016;95(13):9.

Snedecor SJ, Radford M, Kratochvil D, Grove R, Punekar YS. Comparative Efficacy and Safety of Dolutegravir Relative to Common Core Agents in Treatment-Naïve Patients Infected with HIV-1: A Systematic Review and Network Meta-Analysis. BMC Infect Dis. 2019;19(484):14.

Katbi M, Adeoye O, Adedoyin A, Faturiyele I, Adegboye A, Bello M. Virologic Response among Key Populations Living with HIV following a Switch to Dolutegravir-Based Regimen in Southern Nigeria. Int J Virol AIDS. 2020;7(69):8.

Meireles MV, Pascom ARP, Duarte EC, McFarland W. Comparative Effectiveness of First-Line Antiretroviral Therapy: Results from a Large Real-World Cohort After the Implementation of Dolutegravir. AIDS. 2019;33(10):1663-8.

Correa A, Monteiro P, Calixto F, Batista J d’Arc L, de Alencar Ximenes RA, Montarroyos UR. Dolutegravir: Virologic Response and Tolerability of Initial Antiretroviral Regimens for Adults Living with HIV. Menéndez-Arias L, Editor. Plos One. 2020;15(8):10.

Maduka O, Tobin-West C. Adherence Counseling and Reminder Text Messages Improve Uptake of Antiretroviral Therapy in a Tertiary Hospital in Nigeria. Niger J Clin Pract. 2013;16(3):7.

Afolabi B, Afolabi M, Afolabi A, Odewale M, Olowookere SA. Roles of Family Dynamics on Adherence to Highly Active Antiretroviral Therapy among People Living with HIV/AIDS at a Tertiary Hospital in Osogbo, South-West Nigeria. Afr Health Sci. 2013;13(4):920-6.

Negesa L. Adherence to Antiretroviral Therapy and Factors affecting People Living with HIV/AIDS and Taking Antiretroviral Therapy, Dire Dawa Town, Eastern Ethiopia. J Infect Dis Treat. 2017;3(1):6.

Robinson AC, Knowlton AR. Gender Differences in Psychosocial Factors Associated with HIV Viral Suppression among African-American Injection Drug Users. AIDS Behav. 2016;20(2):385-94.